, Asbestos International Agency for Research on Cancer edn, 1977.

K. Straif, L. Benbrahim-tallaa, R. Baan, Y. Grosse, B. Secretan et al., , p.493

N. Freeman, C. Galichet, L. Cogliano, and V. , A review of human carcinogens--part C: metals, 494 arsenic, dusts, and fibres, Lancet Oncol, vol.10, pp.453-454, 2009.

M. C. Camargo, L. T. Stayner, K. Straif, M. Reina, U. Al-alem et al., Occupational exposure to asbestos and ovarian cancer: a meta-analysis, Environ Health Perspect, vol.496, 2011.

, Asbestos International Agency for Research on Cancer edn, 1977.

K. Straif, L. Benbrahim-tallaa, R. Baan, Y. Grosse, B. Secretan et al., , p.493

N. Freeman, C. Galichet, L. Cogliano, and V. , A review of human carcinogens--part C: metals, 494 arsenic, dusts, and fibres, Lancet Oncol, vol.10, pp.453-454, 2009.

M. C. Camargo, L. T. Stayner, K. Straif, M. Reina, U. Al-alem et al., Occupational exposure to asbestos and ovarian cancer: a meta-analysis, Environ Health Perspect, vol.496, pp.1211-1217, 2011.

D. W. Kamp, Asbestos-induced lung diseases: an update, Transl Res, vol.153, pp.143-152, 2009.

M. Goldberg and D. Luce, The health impact of nonoccupational exposure to asbestos: what do 500 we know?, Eur J Cancer Prev, vol.18, pp.489-503, 2009.

P. Nymark, H. Wikman, T. Hienonen-kempas, and S. Anttila, Molecular and genetic changes in 502 asbestos-related lung cancer, Cancer Lett, vol.265, pp.1-15, 2008.

D. Jean, J. Daubriac, F. Le-pimpec-barthes, F. Galateau-salle, and M. C. Jaurand, , p.504, 2012.

, Changes in Mesothelioma With an Impact on Prognosis and Treatment, Arch Pathol Lab Med, vol.136, p.277

L. Calvez, F. Mukeria, A. Hunt, J. D. Kelm, O. Hung et al., , p.507

D. G. Zaridze and P. Hainaut, TP53 and KRAS mutation load and types in lung cancers in relation 508 to tobacco smoke: distinct patterns in never, former, and current smokers, Cancer Res, vol.65, pp.5076-5083, 2005.

L. E. Smith, M. F. Denissenko, W. P. Bennett, H. Li, S. Amin et al., , p.510, 2000.

, Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons, J Natl Cancer Inst, vol.511, issue.92, pp.803-811

B. W. Robinson, A. W. Musk, and R. A. Lake, Malignant mesothelioma, Lancet, vol.366, p.11, 2005.

P. Andujar, J. Wang, A. Descatha, F. Galateau-salle, I. Abd-alsamad et al., , p.514

B. Clin, C. Danel, B. Housset, P. Laurent-puig, F. Le-pimpec-barthes et al., , p.515

J. F. Regnard, A. Renier, J. Zucman-rossi, J. C. Pairon, and M. C. Jaurand, , pp.16-20, 2010.

, inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos, Cancer, vol.517, pp.23-30

D. Vuyst, P. Karjalainen, A. Dumortier, P. Pairon, J. C. Monso et al., , p.519

A. Tossavainen and A. Gibbs, Guidelines for mineral fibre analyses in biological samples: report 520 of the ERS Working Group, Eur Respir J, vol.11, p.13, 1998.

J. C. Pairon, L. Martinon, Y. Iwatsubo, F. Vallentin, M. A. Billon-galland et al., Retention of asbestos bodies in the lungs of welders, Am J Ind Med, vol.522, p.14, 1994.

F. Guida, A. Papadopoulos, G. Menvielle, M. Matrat, J. Fevotte et al., , p.524

M. Carton, S. Paget-bailly, L. Radoi, C. Tarnaud, S. Bara et al., , p.525, 2011.

, Risk of lung cancer and occupational history: results of a French population-based case-control study, the 526 ICARE study, J Occup Environ Med, vol.53, pp.1068-1077

L. Zeng, A. Buard, I. Monnet, C. Boutin, J. Fleury et al., , p.528

M. C. Jaurand, In vitro effects of recombinant human interferon gamma on human mesothelioma 529 cell lines, Int J Cancer, vol.55, pp.515-520, 1993.

J. C. Pairon, E. Orlowski, Y. Iwatsubo, M. A. Billon-galland, G. Dufour et al., , p.531

C. Bignon, J. Brochard, and P. , Pleural mesothelioma and exposure to asbestos: evaluation from 532 work histories and analysis of asbestos bodies in bronchoalveolar lavage fluid or lung tissue in 131 533 patients, Occup Environ Med, vol.51, pp.244-249, 1994.

A. Scherpereel, P. Astoul, P. Baas, T. Berghmans, H. Clayson et al., , p.535

F. Salle, C. Hennequin, G. Hillerdal, C. Le-pechoux, L. Mutti et al., , p.536

J. Van-meerbeeck, D. Waller, and W. Weder, Guidelines of the European Respiratory Society and 537 the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma, Eur, vol.538, 2010.

J. Respir, , vol.35, pp.479-495

H. H. Nelson, D. C. Christiani, J. K. Wiencke, E. J. Mark, J. C. Wain et al., ) k-ras 540 mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without 541 asbestosis, Cancer Res, vol.59, pp.4570-4573, 1999.

K. Husgafvel-pursiainen, A. Karjalainen, A. Kannio, S. Anttila, T. Partanen et al., , p.543

H. , Lung cancer and past occupational exposure to asbestos. Role of p53 and K-ras mutations, Am 544 J Respir Cell Mol Biol, vol.20, pp.667-674, 1999.

X. Wang, D. C. Christiani, J. K. Wiencke, M. Fischbein, X. Xu et al., , p.546

K. T. Kelsey, Mutations in the p53 gene in lung cancer are associated with cigarette smoking and 41, 1995.

C. Whibley, P. D. Pharoah, and M. Hollstein, polymorphisms: cancer implications, Nat Rev, p.599, 2009.

, Cancer, vol.9, pp.95-107

L. Boldrini, S. Gisfredi, S. Ursino, M. Lucchi, G. Greco et al., Effect of the p53 codon 72 and intron 3 polymorphisms on non-small cell lung cancer (NSCLC) 602 prognosis, Cancer Invest, vol.601, pp.168-172, 2008.

A. Matakidou, T. Eisen, and R. S. Houlston, TP53 polymorphisms and lung cancer risk: a 604 systematic review and meta-analysis, Mutagenesis, vol.18, pp.377-385, 2003.

Y. Zhang, A. Bertolino, L. Fazio, G. Blasi, A. Rampino et al., , p.606

D. Wang and W. Sadee, Polymorphisms in human dopamine D2 receptor gene affect gene, pp.20552-20557, 2007.

J. Hull, S. Campino, K. Rowlands, M. S. Chan, R. R. Copley et al., , p.610

B. Keating, J. Knight, and D. Kwiatkowski, Identification of common genetic variation that 611 modulates alternative splicing, PLoS Genet, vol.3, p.46, 2007.

B. Zhang, A. Beeghly-fadiel, J. Long, and W. Zheng, Genetic variants associated with breast-613 cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence, Lancet, vol.614, 2011.

, Oncol, vol.12, p.47

J. M. Schildkraut, E. S. Iversen, M. A. Wilson, M. A. Clyde, P. G. Moorman et al., , p.616

R. C. Bentley, J. R. Marks, and A. Berchuck, Association between DNA damage response and 617 repair genes and risk of invasive serous ovarian cancer, PLoS One, vol.5, p.10061, 2010.